Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-03-002197
Filing Date
2003-09-29
Accepted
2003-09-29 15:30:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A (ORBIMED ADVISORS LLC) sc13ga_092903-arqule.txt SC 13G/A 13617
3 JOINT FILING AGREEMENT ex1-1.txt EX-1.1 2892
4 STATEMENT OF CONTROL PERSON ex2-1.txt EX-2.1 1014
  Complete submission text file 0000947871-03-002197.txt   19581
Mailing Address 19 PRESIDENTIAL WAY WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY WOBURN MA 01801 6173954100
ARQULE INC (Subject) CIK: 0001019695 (see all company filings)

EIN.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48819 | Film No.: 03914821
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 41 MADISON AVE 40TH FL NEW YORK NY 10010 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE